Study: Pharma Companies at Lower Than Expected Risk from Social Media Usage
By Tonya Garcia on November 15, 2011 10:58 AM
A study by Visible Technologies finds that only a tiny percentage of all posts across social media sites rise to the level of the Adverse Event Reporting (AER) government mandate. The AER requires that companies explain negative side effects from the use of a drug in a clinical trial. Only .3 percent of posts had an AER and some of those didn’t actually rise to the government threshold to mandate one.
Greg Singh, regional director of Visible says the results show that while pharma companies “are intimidated by the FDA’s Adverse Events Reporting requirements,” they shouldn’t be quite as hesitant on social media as they have been.

Looking for guidance as you job hunt? Look no further. Join our 
Anyone involved with PR and marketing these days is also involved with social media and digital tactics and strategies.
Those who have registered their reactions to the news yesterday that 



Nadine Cheung
Editor, The Job Post
PRNewser Twitter feed loading...